Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Recurrence-Free Survival in Stage III and High-Risk Stage II Colorectal Cancer After Curative-Intent Treatment

NCT06314958 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06314958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06314958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Recurrence-Free Survival in Stage III and High-Risk Stage II Colorectal Cancer After Curative-Intent Treatment
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Recruiting
Start date
March 15, 2023
Completion date
June 18, 2028
Enrollment
400 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma, colorectal cancer, colorectal cancer recurrent, colorectal cancer stage ii, colorectal cancer stage iii